The Impact of pharmacokinetic-guided prophylaxis on clinical outcomes and healthcare resource utilization in hemophilia a patients: real-world evidence from the CHESS II Study von Grazzi, Enrico Ferri, Sun, Shawn X, Burke, Tom, O'Hara, Jamie

Volltext

EE359 Real-World Utilization, Treatment Frequency, and Bleeding Outcomes on Damoctocog Alfa Pegol in Haemophilia A Care: Insights From a German Cohort Within the CHESS II Study von Zhang, W, Ferri Grazzi, E, O'Hara, J, Burke, T

Volltext

POSB407 The Caregiver Burden Associated with Haemophilia, Real World Evidence from the 'Cost of Haemophilia in Men: A Socioeconomic Survey' (CHESS) II Study von Kritikou, P, Burke, T, Ferri Grazzi, E, O'Hara, J

Volltext

POSC416 The Cost of Haemophilia in Men - A Socioeconomic Survey (CHESS) II Study: Methods: and Key Results von Burke, T, Kritikou, P, Ferri Grazzi, E, O'Hara, J

Volltext

PB0633 Understanding the Requirement for Additional Factor VIII Infusion Associated with Novel Haemophilia A Treatments: An Expert Elicitation Exercise von Santos, S., Ferri Grazzi, E., Burke, T.

Volltext

RWD63 Clinical Outcomes in Non-Inhibitor Severe Haemophilia A Patients Receiving Prophylaxis Across Currently Available Haemophilia A Treatments: Insights Form the ‘Cost of Haemoph... von Blenkiron, T., Hinds, D., Santos, S., Burke, T., Ferri Grazzi, E.

Volltext

EE303 Distribution and Predictors of Haemophilia-Related Direct Medical Cost in the United Kingdom: Analysis of Data From the CHESS I and CHESS II Burden of Illness Studies von Chhabra, A, Woollacott, I, Burke, T, Ferri Grazzi, E, O'Hara, J, Godfrey, J, Laffan, M

Volltext

EE21 The Economic Burden of Severe Haemophilia a without Inhibitors Among Adults with Health Insurance Coverage in the United States: Insights from the "Cost of Haemophilia across... von Ferri Grazzi, E, Blenkiron, T, O'Hara, J, Chen, E, Hinds, D, Burke, T

Volltext

PCR192 Treatment Burden and Its Relationship With Health-Related Quality of Life, Work Productivity and Activity Impairment in Adults With Severe Non-Inhibitor Hemophilia A in the... von Ferri Grazzi, E, Blenkiron, T, Aragon, MJ, Chen, E, Hinds, D, Mead, H, O'Hara, J, Burke, T

Volltext

RWD22 Economic Burden of Moderate and Severe Hemophilia A and B in Spain, Real-World Evidence Insights from the Cost of Hemophilia in Europe: A Socio-Economic Survey II (CHESS II)... von Peral, C., De Lossada Juste, A., Lwoff, N., Espinoza Cámac, N., Martinez, N., Casado, MÁ, Burke, T., Kane, A., Alvir, J., Thakkar, S., Ferri Grazzi, E.

Volltext

RWD71 The Burden of Haemophilia in 5 European Countries: Methods and Results from the Cost of Haemophilia in Europe: A Socioeconomic Survey (CHESS) 2022 von Mancuso, ME, O'Mahony, B, Brighton, S, Smith, C, García-Diego, DA, Arzenton, M, Sannié, T, Curtis, R, Coffin, D, Brennan, F, Blenkiron, T, Burke, T, Grazzi E, Ferri

Volltext

PCR191 Assessing Quality of Care in Haemophilia Using a Value-Based Healthcare Approach von Fornari, C., Cortesi, P.A., Conti, S., Pollio, B., Boccalandro, E., Buzzi, A., Carulli, C., Coppola, A., De Cristofaro, R., Di Minno, G., Dolan, G., Ferri Grazzi, E., Fornari, A., Gualtierotti, R., Hermans, C., Jiménez-Yuste, V., Kenet, G., Lupi, A., Martinoli, C., Mansueto, M.F., Nicolò, G., Tagliaferri, A., Gringeri, A., Molinari, A.C., Mantovani, L.G., Castaman, G.

Volltext